SAGE THERAPEUTICS INC (SAGE) Stock Cash Flow
NASDAQ:SAGE - Nasdaq - US78667J1088 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -354.40M | -400.67M | -541.49M | -532.80M | -457.90M | |||
| Depreciation Amortization | 807.00K | 1.03M | 1.39M | 1.10M | 4.20M | |||
| Change In Working Capital | 1.13M | 84.76M | -67.38M | 5.70M | -18.50M | |||
| Other non cash items | 41.37M | 47.68M | 66.89M | 66.00M | 94.00M | |||
| OPERATING CASH FLOW | -311.09M | -267.19M | -540.59M | -460.00M | -378.20M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | 0.00 | -553.00K | -900.00K | -400.00K | |||
| Other Investing Activity | 173.03M | 266.68M | 443.47M | 326.40M | -1.00B | |||
| INVESTING CASH FLOW | 173.03M | 266.68M | 442.91M | 325.40M | -1.00B | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Stock Issued/Repurchased | 9.87M | 11.18M | 6.93M | 3.10M | 14.70M | |||
| Other Financing Activity | -612.00K | -520.00K | -903.00K | 0.00 | -1.40M | |||
| FINANCING CASH FLOW | 9.25M | 10.66M | 6.03M | 3.10M | 13.30M | |||
| CHANGE IN CASH | -128.81M | 10.15M | -91.64M | -131.50M | -1.37B | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -311.09M | -267.19M | -540.59M | -460.00M | -378.20M | |||
| Capital Expenditure | N/A | 0.00 | -553.00K | -900.00K | -400.00K | |||
| FREE CASH FLOW | -311.09M | -267.19M | -541.14M | -460.90M | -378.60M | |||
All data in USD